Design Therapeutics, Inc. (DSGN) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts DSGN Hot Sheet
Join SI Premium – FREE
Design Therapeutics, Inc. (NASDAQ: DSGN) reported Q3 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Design Therapeutics, Inc. (DSGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- NextPlat Corp (NXPL) Reports Q2 Loss of $0.05
- 360 Living Memories Launches "Monologues & Memories": 360-Degree Immersive Live-Streaming Brings Live Storytelling to Isolated Older Adults Across Three Continents
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
